RIVAR TEVA 15 MG

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Kupite ga zdaj

Prenos Navodilo za uporabo (PIL)
25-01-2024
Prenos Javno poročilo o oceni (PAR)
11-06-2023

Aktivna sestavina:

RIVAROXABAN

Dostopno od:

TEVA ISRAEL LTD

Koda artikla:

B01AF01

Farmacevtska oblika:

FILM COATED TABLETS

Sestava:

RIVAROXABAN 15 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

TEVA ISRAEL LTD, ISRAEL

Terapevtsko območje:

RIVAROXABAN

Terapevtske indikacije:

Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. Treatment of deep vein thrombosis (DVT), and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults.Pediatric populationTreatment of venous thromboembolism (VTE) and prevention of VTE recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Datum dovoljenje:

2021-08-19

Navodilo za uporabo

                                Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN
" (
)
-
1986
15
״
:
15
) ״
Rivaroxaban 15 mg
(
20
״
:
20
) ״
Rivaroxaban 20 mg
(
2
-
"
"
6
–
" "
. .
,
.
.
,
.
.
.
.
.
.
.
1 (
?
15 "
20 "
:

,
( )
)
,
,
:
,
75
,
,(
.

(
)
(
)
/
.
15
"
20
"
18
30
"
:

,
5 . :
-
-
)
10a
)
Xa
(
(
.
2 ( :

(
)
)
2
-
"
"
6
–
"
"
.(

.

,
,
:
)
(
.

:
)
,
,(
,
.

.

.
.
Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN
. .
: ,

:
o
,
)
3
-
"?
"
(
.
o
:)
,
,(
,
)
2
-
"
-
("
.
o
.
o
.
o
,
:
,
,
-
(
)
.
o
.(
)
o
)
(
.

.

-
)
.
,(

.
.
.

,
.

.

-
:
(
)
o
.
o
.
,
-
30
"
.
.
- , , ,
.
:

:
)
,(
, ,
,
.

-
.

.(
,
:
)

-
)
HIV
(
/
:)
.(

,
:)
K
.(

:)
]
.([

.
,
Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN

)
]
SSRIs
[
]
SNRIs
[
(
.
,
.
. : ,

.(
,
,
:) (
)

.
'
)
St. John's wort
,
.(

(
)
.
,
.
.
. ,
.
,
.
,
,
.
) (
)
(
)
4
-
"
.("
,
,
.
.
-
-
,
.
-
1
)
23
( ״
."
"
3 (
?
.
.
-
.

()
,
20
.
״
,
15
.
״
:
)
-
PCI
,(
15
״
,
. :

,
15
"
3
,
20
"
.
6
,
10
״
.
20
"
3
,
15
"
,
.
Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN
,
-
.

30
" -
50
"
15
"
.

50
"
20
״
.
)
(
.
.
.
:
.
,
,
.
.
.
.
,
.
,
.
,
.
.
,
.
.
.
.
.
,
.
.
.
,
.
. /
,
.

-
30
,
.

-
30
,
.
,
.
.
.
.
,
.
 ,
15
"
20
״
,
,
!
.
Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN

15
"
,
.
15
.
"
15
"
30
"
.
15
.
״
-
.
,
.
. ! .
. . ,
4 ( , . . .
,
.
.()
. :
:
-
-
,
,
,
,
)
!
,
.
.(
-
.
-
, ,
,
,
,
,
,
.(
)
. :
-
,
,
)
Stevens-
Johnson syndrome/ Toxic Epidermal Necrolysis
.(
-
,
,
,
)
DRESS
.(
)
10,000
(
. :
-
, , ,
;
;
.
;
;
,
)
10,000
(
;
)
100
.( ,
)
COMMON
) (
10 :(
-
,
-
,
,
,(
)
-
(
)
-
)
( ,
-
-
-
-
-
Rivar Teva 15mg, 20mg MF Notification 01/2024 CLEAN
-
-
)
-
(
-
-
, ,
,
,
-
(
)
-
,
)
, ,(
-
,
-
)
UNCOMMON
) (
100
:(
-
-
-
,
)
"
"
(
-
-
( ,
)
-
,
-
)
-
(
-
,
-
-
-
-
-
(
)
)
RARE
) (
1,000
( :
-
-
)
(
)
,(
)
(
-
(
)
-
-
(
)
)
VERY RARE
) (
10,000 :(
-
,
(
) )
:(
-
-
)
(
-
, ,
,
,
(
)
,
. :
)
VERY COMMON
) (
10 :(
-
-
-
-
Rivar Teva 15mg, 20mg MF
                                
                                Preberite celoten dokument
                                
                            

Dokumenti v drugih jezikih

Navodilo za uporabo Navodilo za uporabo arabščina 21-09-2023
Navodilo za uporabo Navodilo za uporabo hebrejščina 17-01-2024

Opozorila o iskanju, povezana s tem izdelkom

Ogled zgodovine dokumentov